Mystic Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Sell |
25,700
-2,300
| -8% | -$72.5K | 0.2% | 105 |
|
|
2025
Q1 | $917K | Sell |
28,000
-200
| -0.7% | -$6.55K | 0.24% | 95 |
|
|
2024
Q4 | $1.02M | Sell |
28,200
-40
| -0.1% | -$1.45K | 0.27% | 87 |
|
|
2024
Q3 | $881K | Buy |
28,240
+300
| +1% | +$9.35K | 0.33% | 80 |
|
|
2024
Q2 | $747K | Sell |
27,940
-1,300
| -4% | -$34.8K | 0.3% | 83 |
|
|
2024
Q1 | $997K | Sell |
29,240
-100
| -0.3% | -$3.41K | 0.41% | 73 |
|
|
2023
Q4 | $849K | Sell |
29,340
-500
| -2% | -$14.5K | 0.41% | 75 |
|
|
2023
Q3 | $823K | Buy |
29,840
+500
| +2% | +$13.8K | 0.46% | 72 |
|
|
2023
Q2 | $882K | Sell |
29,340
-1,400
| -5% | -$42.1K | 0.47% | 72 |
|
|
2023
Q1 | $1.11M | Hold |
30,740
| – | – | 0.61% | 59 |
|
|
2022
Q4 | $1.1M | Sell |
30,740
-100
| -0.3% | -$3.57K | 0.62% | 59 |
|
|
2022
Q3 | $1.04M | Sell |
30,840
-1,750
| -5% | -$59.2K | 0.67% | 54 |
|
|
2022
Q2 | $942K | Sell |
32,590
-500
| -2% | -$14.5K | 0.57% | 62 |
|
|
2022
Q1 | $1.07M | Buy |
33,090
+1,000
| +3% | +$32.3K | 0.57% | 62 |
|
|
2021
Q4 | $935K | Buy |
+32,090
| New | +$935K | 0.44% | 71 |
|